India cancels orders for Chinese Covid-19 test kits, says won't lose money

States must stop using rapid antibody test kits procured from Guangzhou Wondfo Biotech and Zhuhai Livzon Diagnostics, said ICMR

covid-19 test, coronavirus testing
A woman gives samples to a medic for Covid-19 tests, during the nationwide lockdown to curb the spread of coronavirus, in Ranchi. Photo: PTI
BS Web Team New Delhi
2 min read Last Updated : May 27 2020 | 8:07 AM IST
India has cancelled orders given to two Chinese companies for providing Covid-19 test kits after finding them faulty in field conditions, said the government on Monday. Not a single rupee will be lost to the companies, it said.
 
States must stop using rapid antibody test kits procured from Guangzhou Wondfo Biotech and Zhuhai Livzon Diagnostics, said the Indian Council of Medical Research (ICMR), according to news agency IANS. "The results showed wide variation in their sensitivity, despite early promise of good performance for surveillance purposes," it said in a statement.

"In view of this, states are advised to stop using these kits procured from the above-mentioned companies and return them to be sent back to the suppliers."
 
ICMR had provided rapid antibody test kits to states with instructions that they be used for surveillance alone. However, Rajasthan and West Bengal complained that the new test kits had only 5.4 per cent accuracy. Opposition parties, too, questioned the government's purchase as well.

Congress leader Rahul Gandhi on Monday alleged that some people were indulging in profiteering while supplying rapid test kits for COVID-19 to the government and demanded that Prime Minister Narendra Modi take immediate action against them.

Enable GingerCannot connect to Ginger Check your internet connection
or reload the browserDisable in this text fieldEditEdit in GingerEdit in Ginger×

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :Coronavirushealthcare technologiesHealthcare in IndiaGovernment hospitalsIndia China relations

Next Story